Skip to main navigation Skip to search Skip to main content

Ultrasound-Enhanced Self-Exciting Photodynamic Therapy Based on Hypocrellin B

  • Ying Ding
  • , Weimin Liu*
  • , Jiasheng Wu
  • , Xiuli Zheng
  • , Jiechao Ge
  • , Haohui Ren
  • , Wenjun Zhang
  • , Chun-Sing Lee
  • , Pengfei Wang*
  • *Corresponding author for this work

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

Abstract

Peroxalate CL as an energy source to excite photosensitizers has attracted tremendous attention in photodynamic therapy (PDT). In this work, peroxyoxalate CPPO and hypocrellin B (HB)-based nanoparticles (CBNPs) for ultrasound (US)-enhanced self-exciting PDT were designed and prepared. CBNPs showed an excellent therapeutic effect against cancer cells with the assistance of US. This US-enhanced-chemiluminescence system avoids the dependence on external light and provides an example for inspiring more effective and precise strategies for cancer treatment.
Original languageEnglish
Pages (from-to)1221–1224
JournalChemistry - An Asian Journal
Volume16
Issue number10
Online published21 Apr 2021
DOIs
Publication statusPublished - 17 May 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Keywords

  • Hypocrellin B
  • Peroxyoxalate
  • Self-exciting photodynamic therapy
  • Ultrasound-enhanced chemiluminescence

Fingerprint

Dive into the research topics of 'Ultrasound-Enhanced Self-Exciting Photodynamic Therapy Based on Hypocrellin B'. Together they form a unique fingerprint.

Cite this